Does Chia Blood Glucose Meta-Analysis work?

Updated August 2026

Quick Answer

Chia Blood Glucose Meta-Analysis has evidence relevant to strength of evidence and what the studies can or cannot prove, but conclusions should stay close to the cited sources. One representative finding is: 3 Numerous large-scale clinical studies have confirmed that blood glucose control in diabetic patients can effectively reduce the risk of cardiovascular diseases and mortality.

Key Takeaways

  • 013 Numerous large-scale clinical studies have confirmed that blood glucose control in diabetic patients can effectively reduce the risk of cardiovascular diseases and mortality. [Hsu Su-Han (2026)]
  • 02A clinical trial published in 2000 demonstrated that for patients with type 2 diabetes, a 1% reduction in HbA1c was associated with a 14% decrease in the risk of myocardial infarction, a 21% reduction in diabetes-related mortality, and a 37% reduction in complications related to peripheral vascular disease []. [Hsu Su-Han (2026)]
  • 03A meta-analysis published in 2004, primarily based on Western studies, found that face-to-face teaching, using the cognitive reframing teaching method combined with practice, could reduce patients’ HbA1c by 0.32% []. [Hsu Su-Han (2026)]
  • 041 According to the International Diabetes Federation (IDF) [], reported that 11.1% of the adult population (20–79 years) has diabetes. [Hsu Su-Han (2026)]
The current Migaku evidence database contains 2 reusable source documents for Chia Blood Glucose Meta-Analysis. This answer focuses on strength of evidence and what the studies can or cannot prove. - 3 Numerous large-scale clinical studies have confirmed that blood glucose control in diabetic patients can effectively reduce the risk of cardiovascular diseases and mortality. [Hsu Su-Han (2026); evidence level 3] - A clinical trial published in 2000 demonstrated that for patients with type 2 diabetes, a 1% reduction in HbA1c was associated with a 14% decrease in the risk of myocardial infarction, a 21% reduction in diabetes-related mortality, and a 37% reduction in complications related to peripheral vascular disease []. [Hsu Su-Han (2026); evidence level 3] - A meta-analysis published in 2004, primarily based on Western studies, found that face-to-face teaching, using the cognitive reframing teaching method combined with practice, could reduce patients’ HbA1c by 0.32% []. [Hsu Su-Han (2026); evidence level 3] - 1 According to the International Diabetes Federation (IDF) [], reported that 11.1% of the adult population (20–79 years) has diabetes. [Hsu Su-Han (2026); evidence level 3] - Results Higher oleate levels were linked to lower insomnia risk (β: -5.99, p = 0.01), but insomnia did not alter oleate levels. [Fan HY (2026); evidence level 4] Evidence levels are sorting aids, not final clinical grades. Level 1 usually indicates systematic-review style evidence, level 2 indicates randomized trials or public-health guidance, and lower levels need more cautious wording. This page is educational. People with medical conditions, pregnancy, medication use, or unusual symptoms should ask a qualified clinician before changing supplements, medication, or treatment routines.

Sources

  1. Patient decision aid–supported shared decision making and short-term decision-making outcomes in type 2 diabetes: a prospective observational comparative study
  2. Causal relationships between insomnia and blood metabolome: a Mendelian randomization study with mouse experimental validation.